Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

6.7%

1 terminated/withdrawn out of 15 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

27%

4 trials in Phase 3/4

Results Transparency

0 of 1 completed trials have results

Key Signals

6 recruiting

Enrollment Performance

Analytics

N/A

4(40.0%)

Phase 3

3(30.0%)

Phase 2

2(20.0%)

Phase 4

1(10.0%)

10Total

N/A(4)

Phase 3(3)

Phase 2(2)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (15)

Showing 15 of 15 trials

NCT07559201Not ApplicableRecruiting

Theranostic Applications of Radionuclides in Prostate Cancer

Role: lead

NCT02633202Phase 3Completed

Concurrent Chemotherapy for the Intermediate Risk Nasopharyngeal Carcinoma In Intensity-modulated Radiotherapy Era

Role: collaborator

NCT07141056Recruiting

The Impact of Emotional Stress on Immunotherapy Outcomes in Liver Cancer Patients: A Multi-Cohort Study

Role: lead

NCT06492460Phase 3Recruiting

2 Courses of Concurrent Cisplatin Chemoradiotherapy After Surgery for High-risk Head and Neck Squamous Cell Carcinoma

Role: collaborator

NCT06763666Phase 4Not Yet Recruiting

CLAG+VEN vs CLAG in the Treatment of Relapsed/Refractory AML

Role: collaborator

NCT05892354Not ApplicableRecruiting

Effect of Immunonutrients on Oral Mucositis in Nasopharyngeal Carcinoma Patients After Chemoradiotherapy

Role: collaborator

NCT06506318Recruiting

A Joint Model Based on Deep Learning to Predict Multidrug-resistant Klebsiella Pneumoniae Liver Abscess

Role: collaborator

NCT05717790Not ApplicableRecruiting

Concurrent and Adjuvant Nimotuzumab Combined With Induction Chemotherapy Plus Chemoradiation in Nasopharyngeal Carcinoma

Role: collaborator

NCT02874651Phase 2Terminated

ADjuVant Apatinib in Nasopharyngeal Carcinoma Patients With Residual Epstein-Barr Virus (EBV) DNA Following Radiotherapy

Role: collaborator

NCT03236636Phase 3Unknown

The Phase III Study of Icaritin Versus HUACHANSU PIAN in Hepatocellular Carcinoma Subjects

Role: collaborator

NCT03025854Unknown

Prospective Study for Prognostic Biomarkers of Nasopharyngeal Carcinoma

Role: collaborator

NCT03048305Unknown

Prospective Study for Molecular Biomarkers of Normal Nasopharyngeal Tissue

Role: collaborator

NCT03661671Not ApplicableUnknown

Application of Linked Color Imaging（LCI） in Diagnosis of Early Gastric Cancer(EGC)

Role: collaborator

NCT03130270Phase 2Unknown

Maintenance Treatment of Apatinib in Nasopharyngeal Carcinoma

Role: lead

NCT02199990Unknown

The Effect of Propofol or Etomidate on Cognitive Function for 1-3 Years Old Children

Role: lead

All 15 trials loaded